Greencare Capital exits cannabis to focus on crypto and other sectors
To reflect the change, the company will now be called MaxRS Ventures plc.
To reflect the change, the company will now be called MaxRS Ventures plc.
Get up to date with the latest financial results from Jazz Pharma, Flora Growth, Khiron, MGC Pharma, CBD of Denver and Tilray.
Cannabis Europa explored the pros and cons of being a first mover in the nascent European industry.
Analysis from Prohibition Partners underscores how the UK’s inability to embrace the industry could come at a significant economic cost.
A new report from Fact.MR shows the market will grow at a CAGR of 31 per cent until 2032.
The CBX Stock Exchange is a B2B trading platform for raw cannabis materials.
The sales estimates were based on a survey of research firms covering the financial outlook of Aurora.
The cannabis producer’s stock shot up by 215 per cent on its first day of trading followed by a further 91 per cent increase yesterday.
Companies across the cannabis industry announce financial results for the first quarter of 2022, Cannabis Wealth rounds up the results of six major firms expanding within the UK medical cannabis space. 2021 was a positive year for cannabis businesses with 165 per cent year-over-year growth in cannabis equity capital raises and a series of high…